European Journal of Cancer
Volume 46, Issue 16 , Pages 3016-3021, November 2010

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation☆

  • Maja J.A. de Jonge

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • Authors contributed equally.
    • Corresponding Author InformationCorresponding author: Tel.: +31 10 439 1760; fax: +31 10 439 1003.
    • ,
  • Marije Slingerland

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • Authors contributed equally.
    • ,
  • Walter J. Loos

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Erik A.C. Wiemer

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Herman Burger

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Ron H.J. Mathijssen

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Judith R. Kroep

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • ,
  • Margret A.G. den Hollander

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • ,
  • Diane van der Biessen

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Mei-Ho Lam

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Jaap Verweij

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Hans Gelderblom

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands

Received 31 May 2010; accepted 14 July 2010. published online 30 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This clinical trial was registered as EUDRACT 2006-006637-40.

PII: S0959-8049(10)00693-3

doi:10.1016/j.ejca.2010.07.015

European Journal of Cancer
Volume 46, Issue 16 , Pages 3016-3021, November 2010

Article Tools

* Image Usage & Resolution